Common Equity: The sum of all common equity items.
Satellos Bioscience Inc. (T.MSL) had Common Equity of 69.44M for the most recently reported fiscal quarter, ending 2026-09-30.
| Income Statement Financials | |
-- |
|
-15.63M |
|
-- |
|
-- |
|
-- |
|
-16.34M |
|
-- |
|
-15.57M |
|
-15.57M |
|
-15.63M |
|
-15.63M |
|
-15.63M |
|
-15.63M |
|
-16.34M |
|
-16.34M |
|
21.18M |
|
21.18M |
|
0.00 |
|
0.00 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
81.14M |
|
-- |
|
-- |
|
-- |
|
11.70M |
|
|
Common Equity |
69.44M |
69.44M |
|
69.44M |
|
21.22M |
|
| Cash Flow Statement Financials | |
-36.17M |
|
-40.62M |
|
71.81M |
|
13.72M |
|
8.64M |
|
-5.08M |
|
3.54M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.93 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-36.17M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-22.51% |
|
-22.51% |
|
-19.26% |
|
-22.51% |
|
3.27 |
|
-1.71 |
|
-1.71 |
|